USPTO serial 79064112
I.Q.A.
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, DEBRA ANN
- Law office
- TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with I.Q.A.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CZ-150 00 Praha 5, CZ
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; bacterial, chemical, and biological preparations for medical and veterinary purposes,namely, for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases,immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; chemico-pharmaceutical preparations for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; herbal teas for medicinal purposes, medicinal herbs, drugs for medical purposes, namely, for the treatment of immunity disorders, skin disorders; diagnostic preparations for medical and veterinary purposes, frimigating preparations, namely, insecticides, pesticides, fungicides and herbicides; enzyme preparations, namely, improving inflammatory disorders; chemical preparations for analyzing DNA for medical purposes, bacteriological cultures media, vitamins for medical and veterinary purposes, antibiotics for the treatment of diseases caused by gram-positive and gram-negative pathogens; amino acids for medical purposes, analgesics, anesthetics, namely, for non-surgical use; cotton swabs for medical purposes, balms for medical purposes, albuminous foodstuffs specially adapted for medical purposes, diabetic sugar for medical purposes, suppositories for the treatment of pain; dietetic food and drinks adapted for medical use; hormones for medical purposes, capsules sold empty for medicines, first-aid boxes being first-aid kits, ointments for medical purposes for the treatment of skin disorders; adhesive plasters for topical application of drugs; isotopes, namely, radio-isotope markers for therapeutic or diagnostic use; super-oxidized water, radioactive substances, namely, diagnostic radio pharmaceutical preparations; radium, namely, as a component of radio-isotope markers for therapeutic or diagnostic use; esters, namely, as antihyperlipoproteinic drugs; tablets for the treatment of proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; hemoglobin, herbicides, anesthetics, namely, chloroform; antiseptic, namely, iodoform, medicated jujube for the treatment of skin disorders; blood plasma, lactose, for use as a dietary supplement; opiates for the treatment of sleep disturbances; purgatives; insecticides | SECTION 70 - CANCELLED | — |
| 042 | Research and development in the field of pharmacy and medicine for others, research relating to healthcare, science and technology in the field of pharmacy, medicine, biotechnologies, chemistry; clinical, medical and scientific research, expert analysis in medicine, pharmacy, veterinary medicine, biological, bacteriological and chemical research, pharmaceutical testing; development and studies in the field(s) of chemistry, biochemistry, pharmacology, medicine, biotechnologies; quality control for others; medical physical, physical-chemical and chemical testing of medicines including tests relating to storing samples for faster, more sustainable, reliable studies; cosmetics research, expertise, namely, consultation and analysis concerning safety of used compounds; development of new technologies in the field(s) of chemistry analysis; scientific technical analysis; testing and measuring services relating to chemical and physical stability of drugs and chemical compounds, biosimilarity of drugs, bioequivalence of drugs; material testing, consultancy relating to biochemistry, development of computer hardware and software, medical laboratory research services; pharmaceutical discovery services, namely, pharmaceutical research; development of pharmaceutical compositions, chemical analysis, physics research, geological surveys, pharmaceutical clinical studies using web databases, design of computer systems and construction of Internet sites in the field of pharmacy; consultancy in the fields of computer applications and information technology; rental of software; installation, repair, maintenance and servicing of software; creation of interactive applications enabling the transfer and creation of graphic images using the Internet; software design, creation and maintenance of web pages for clients; hosting of web pages; installation of computer programs, computer system design, Internet database system and Internet application programming; updating and maintenance of computer programs, duplication of computer programs, technical studies in the field of computers and software; graphic arts designing; consultancy in the field of computer and information technology | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 29, 2019 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| Jan 11, 2019 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jan 10, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 5, 2011 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 14, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 14, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 23, 2010 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 8, 2010 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 8, 2010 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 14, 2010 | MAB0 | ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE | — |
| Jan 14, 2010 | ABN0 | ABANDONMENT - INCOMPLETE RESPONSE | — |
| Jun 12, 2009 | NAUD | NOTICE OF UNRESPONSIVE AMENDMENT - MAILED | — |
| Jun 11, 2009 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| May 12, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| May 12, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2009 | PAPER RECEIVED | — | |
| Apr 10, 2009 | NAUD | NOTICE OF UNRESPONSIVE AMENDMENT - MAILED | — |
| Apr 10, 2009 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Mar 24, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 18, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 14, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 13, 2009 | FAXX | FAX RECEIVED | — |
| Feb 17, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 17, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 14, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 13, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 6, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 6, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 5, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |